These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features. Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249 [TBL] [Abstract][Full Text] [Related]
3. Conformal radiotherapy for detectable PSA following radical prostatectomy: efficacy and predictive factors of recurrence. Delongchamps NB; Zerbib M; Mejean A; Rouach Y; Debre B; Peyromaure M Can J Urol; 2009 Oct; 16(5):4813-9. PubMed ID: 19796456 [TBL] [Abstract][Full Text] [Related]
4. Need for high radiation dose (>or=70 gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients. Cozzarini C; Montorsi F; Fiorino C; Alongi F; Bolognesi A; Da Pozzo LF; Guazzoni G; Freschi M; Roscigno M; Scattoni V; Rigatti P; Di Muzio N Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):966-74. PubMed ID: 19619960 [TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen (PSA) in the monitoring of prostate cancer after radical prostatectomy and external beam radiation. Schaefer U; Witt F; Schueller P; Micke O; Willich N Anticancer Res; 2000; 20(6D):4989-92. PubMed ID: 11326654 [TBL] [Abstract][Full Text] [Related]
6. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995. Kupelian P; Kuban D; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):415-9. PubMed ID: 15667961 [TBL] [Abstract][Full Text] [Related]
7. Identification of factors predicting response to adjuvant radiation therapy in patients with positive margins after radical prostatectomy. Kamat AM; Babaian K; Cheung MR; Naya Y; Huang SH; Kuban D; Babaian RJ J Urol; 2003 Nov; 170(5):1860-3. PubMed ID: 14532793 [TBL] [Abstract][Full Text] [Related]
8. Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era. Kupelian P; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A; Kuban D Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):795-9. PubMed ID: 15925452 [TBL] [Abstract][Full Text] [Related]
9. Prostate-specific antigen (PSA) and radiotherapy in locally confined prostate cancer. Schaefer U; Micke O; Willich N Anticancer Res; 1999; 19(4A):2645-8. PubMed ID: 10470211 [TBL] [Abstract][Full Text] [Related]
15. Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy. Cheung R; Tucker SL; Lee AK; de Crevoisier R; Dong L; Kamat A; Pisters L; Kuban D Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):993-1002. PubMed ID: 15752878 [TBL] [Abstract][Full Text] [Related]
16. [Salvage radiotherapy for pT3 prostate cancer with PSA failure after radical prostatectomy]. Wakita T; Hayashi N; Fuwa N Hinyokika Kiyo; 2005 Sep; 51(9):575-80. PubMed ID: 16229369 [TBL] [Abstract][Full Text] [Related]
17. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer. Hiratsuka J; Jo Y; Yoshida K; Nagase N; Fujisawa M; Imajo Y Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):684-90. PubMed ID: 15183471 [TBL] [Abstract][Full Text] [Related]
18. Radiotherapy after radical prostatectomy: does transient androgen suppression improve outcomes? King CR; Presti JC; Gill H; Brooks J; Hancock SL Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):341-7. PubMed ID: 15145146 [TBL] [Abstract][Full Text] [Related]
19. Postoperative radiotherapy after radical prostatectomy for prostate carcinoma: the experience of the Brescia Radium Institute. Caraffini B; De Stefani A; Vitali E; Magri E; Tonoli S; Frata P; Gatta R; Magrini SM Radiol Med; 2006 Aug; 111(5):741-7. PubMed ID: 16721508 [TBL] [Abstract][Full Text] [Related]
20. Long-term benefits of elective radiotherapy after prostatectomy for patients with positive surgical margins. Teh BS; Bastasch MD; Mai WY; Kattan MW; Butler EB; Kadmon D J Urol; 2006 Jun; 175(6):2097-101; discussion 2101-2. PubMed ID: 16697811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]